# Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes

> **NCT07060898** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Amazentis SA** · enrollment: 650 (actual)

## Conditions studied

- Aging
- Cognitive Decline
- Brain Fog
- Cognitive Function

## Interventions

- **DIETARY_SUPPLEMENT:** Active Product
- **DIETARY_SUPPLEMENT:** Placebo Product

## Key facts

- **NCT ID:** NCT07060898
- **Lead sponsor:** Amazentis SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-29
- **Primary completion:** 2025-11-20
- **Final completion:** 2026-11-20
- **Target enrollment:** 650 (ACTUAL)
- **Last updated:** 2026-03-06

## Collaborators

- Radicle Science (sponsor)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07060898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07060898, "Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT07060898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*